Actually, if you care to read though my post history (don't blame you if you don't); you'll find I was genuinely curious about an outlicense deal of the B Cell platform to free up capital for the rest of the IP months before IMU ever floated this idea. I was derided for suggesting such heresy by these very IMU class clowns.
But, despite suggesting this possibly, IMU have instead issued convertible notes to sharks. Doesn't bode well for the trial updates that are many months overdue.
Yet, you've still got the likes of Alcp, spouting off nonsense regarding excellent clinical results and multi billion dollar valuations - with absolutely naught to justify it. Blatant ramping should be called out for what it is. IMU has ~29k shareholders and I very much doubt that >5% of those will ever make a return here.
IMU Price at posting:
4.1¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)